With Increasing Prevalence of Cancer Have Garnered High Popularity of Fiducial Markers Among Radiotherapy Centers And Cancer Institutes

Fact.MR – A Market Research and Competitive Intelligence Provider: According to Fact.MR, the global fiducial markers market is set to expand at over 8% CAGR through 2031.

Adoption of Cutting-Edge Technologies in Hospitals and Medical Sectors Has Boosted the Growth of Manufacturers of Fiducial Markers

Fact.MR – A Market Research and Competitive Intelligence Provider: According to Fact.MR, the global fiducial markers market is set to expand at over 8% CAGR through 2031. The fiducial markers market is predicted to rise as the incidence of various cancers such as lung, prostate, and breast increases, as well as the usage of radiotherapy for oncology treatments.

Manufacturers and suppliers are expected to see increased demand in the coming years as demand for fiducial markers in radiotherapy grows. Fact.MR provides a comprehensive assessment of the global fiducial markers market, including growth drivers, potential, and demand-supply trends for the next 10 years.

“With incorporation of cutting-edge technologies in modern healthcare systems, demand for fiducial markers has grown significantly in the past years, especially in radiotherapy. According to the report published by the International Journal of Medical Sciences, nearly 50% of all cancer patients receive radiation therapy during their course of illness, while it contributes towards 40% of curative treatment for cancer,”

says a Fact.MR analyst.

Request a report sample to gain comprehensive insights at https://www.factmr.com/connectus/sample?flag=S&rep_id=1026

Manufacturers are seeing a surge in demand as fiducial markers become a routine tool for image-guided radiotherapy. According to the Cancer Control Organization's report "Radiotherapy in Global Cancer Control," radiotherapy equipment availability ranged from 8.6 machines per million people in high-income countries (as defined by the World Bank) to 1.6 per million in high-middle income countries, 0.71 in low-middle income countries, and 0.21 per million in low-income countries. This information demonstrates the potential for fiducial markers to develop in the coming years.

Key Takeaways from Fiducial Markers Market Study

  • Germany remains the leading country in the world’s largest market for fiducial - Europe
  • The United States will remain the epicenter of the world’s largest fiducial markers market - North America - with a share of more than 85% in the region.
  • China, Japan, Indonesia, and others to remain highly sought-after markets for suppliers.
  • High demand for pure gold fiducial markers to fuel sales.
  • Growing requirement of photon therapy to propel growth of fiducial manufacturers.
  • In terms of disease site, prostate cancer to emerge as a dominant segment.
  • Radiotherapy centers to lead market demand in terms of end user.

The Report's Covered Segments:

From 2016 through 2027, this research anticipates revenue growth at the global, regional, and country levels, as well as an analysis of current industry trends in each of the sub-segments. Fact.MR has segmented the global fiducial markers market research by product, modality, application, end user, and region for the purposes of this study:

Request Fiducial markers Market Customization at https://www.factmr.com/connectus/sample?flag=RC&rep_id=1026

Segmentation by Category

Product

  • Polymer Based Markers
  • Metal Based Markers
  • Pure Gold Markers
  • Liquid Based Markers

Modality

  • Photon Therapy
  • Proton Therapy
  • Tomotherapy
  • Cyberknife

Disease Site

  • Head & Neck
  • Breast
  • Lung
  • Abdomen
  • Prostate
  • Kidney
  • Cervix or Other Gynaecologic Organs

End User

  • Hospitals
  • Cancer Research Institutes
  • Radiotherapy Centers

Who is Winning in this Space?

As significant market competitors increase their investments, competition in the fiducial markers industry is becoming increasingly fierce. Key players are broadening their offerings in order to take advantage of new opportunities.

For instance,

  • Boston Scientific launched its new LumiCoil™ Platinum Fiducial Markers, which are designed for clear visibility in CT, X-ray, EUS, and others, in January 2018.
  • Stellar Medical launched its new range of fiducial markers, such as Stellar Gold Fiducial Markers, Soft Tissue Implantable Gold Fiducial Markers, and others, in 2019.

Enquire Before Buying Here – https://www.factmr.com/connectus/sample?flag=EB&rep_id=1026

Fact.MR’s Domain Knowledge in Healthcare

Our healthcare consulting team guides organizations at each step of their business strategy by helping you understand how the latest influencers account for operational and strategic transformation in the healthcare sector. Our expertise in recognizing the challenges and trends impacting the global healthcare industry provides indispensable insights and support – encasing a strategic perspective that helps you identify critical issues and devise appropriate solutions.

Explore Fact. MR’s Coverage on the Healthcare Domain

Radiotherapy Devices Market - Sales of radiotherapy equipment are slated to accelerate at a CAGR of 7% to top US$ 10 Bn by 2031. Demand for linear accelerator devices, which holds the highest market share, is set to increase at a CAGR of 6% across the assessment period of 2021 to 2031.

Radiation Proctitis Treatment Market - Demand for acute radiation proctitis treatment is high, while over the coming years, the need for chronic radiation proctitis treatment is expected to increase significantly.

Radiation Dermatitis Treatment Market - High demand is anticipated for topical hydrophilic creams, likely to yield 33% of global market revenue. The global radiation dermatitis treatment market to register a high market value, reaching US$ 700 Mn by the end of the 2021-2031 assessment period, registering a CAGR of 5%.

About Fact.MR

Fact.MR is a market research and consulting agency with deep expertise in emerging market intelligence. Spanning a wide range – from automotive & industry 4.0 to chemical and materials, technology to even the most niche categories. 80% of Fortune 1000's trust us in critical decision making.

MarketNgage is powered by Fact.MR – our Unified Intelligence Engine, a revolutionary Market Research Subscription platform with a flexible pricing to suit your needs.
 

You can access all our chemical and materials research reports by signing up with MarketNgage’s Market Research Subscription with FREE credits. MarketNgage is powered by Fact.MR – A Fully integrated research solution for seamless single-window access Widest coverage on emerging markets, nascent products, and disruptive technologies.

Contact:

Mahendra Singh
US Sales Office
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583
E: sales@factmr.com
 

Source: Fact.MR